AMERICAN SOCIETY CLINICAL PATHOLOGY

Brand Owner (click to sort) Address Description
ASCP American Society for Clinical Pathology, Inc. Suite 1600 33 West Monroe Chicago IL 60603 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY;Color is not claimed as a feature of the mark.;Association services, namely, promoting the interests of clinical pathologists;
ASCP American Society for Clinical Pathology, Inc. Suite 1600 33 West Monroe Chicago IL 60603 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY;Association services, namely, promoting new developments in medicine and science as they relate to pathology and laboratory medicine;
ASCP ASSET WAREHOUSE American Society for Clinical Pathology Suite 1600 33 West Monroe Street Chicago IL 60603 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY ASSET WAREHOUSE;Providing an on-line computer database in the field of pathology, namely, digital images, documents, articles, and materials;
ASCP PATIENT CHAMPIONS American Society for Clinical Pathology Suite 1600 33 West Monroe Street Chicago IL 60603 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY PATIENT CHAMPIONS;Promoting awareness of the role of the medical laboratory in patient care; Public advocacy to promote awareness of the role of the medical laboratory in patient care;PATIENT CHAMPIONS;
ASCPEDIA American Society for Clinical Pathology Suite 1600 33 West Monroe Street Chicago IL 60603 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY PEDIA;Providing an on-line computer database in the field of pathology featuring non-downloadable material in the nature of digital images, documents and articles about the nature, effects, causes and consequences of disease;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.